Jan 4, 20235 min readHow does Lecanemab compare to other Alzheimer's assets?Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...
